Literature DB >> 11068160

Ondansetron in multiple sclerosis.

A D Macleod1.   

Abstract

Two young women with chronic nausea and vertigo caused by multiple sclerosis responded to the introduction and maintenance of the 5HT3 receptor antagonist, ondansetron. Palliative care is a neglected aspect of management of degenerative neurological diseases and these cases highlight the approaches that may be used to manage difficult symptoms in the population with multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11068160     DOI: 10.1016/s0885-3924(00)00205-0

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  3 in total

1.  [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].

Authors:  G Benze; A Geyer; B Alt-Epping; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

Review 2.  Pharmacological treatment of vertigo.

Authors:  Timothy C Hain; Mohammed Uddin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Comparison of the effects of amantadine and ondansetron in treatment of fatigue in patients with multiple sclerosis.

Authors:  Mojtaba Khazaei; Ashkan Karevan; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Clin Transl Med       Date:  2019-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.